Kristiansand, Norway – Patients with fragility hip fracture experience a long term negative impact on their health related quality of life (HRQOL). However, for fragility wrist fracture, several studies indicate no long term negative effects on HRQOL. A better understanding of the impact of these fractures on HRQOL will inform health policy and decision making in this area.
In a recent study, “Comparing 15D and SF-6D performance in fragility wrist and hip fracture patients in a two-year follow-up case control study,” published in Value in Health, the performance of two measures of HRQOL (the 15D and SF-6D) was tested in fragility wrist and hip fracture patients in a two-year follow-up case control study. The study was carried out by Associate Professor Gudrun Rohde, Professor Torbjorn Moum and Professor Glenn Haugeberg.
The findings from the study illustrate how fragility wrist fracture can negatively impact HRQOL. The study confirms that hip fracture has a sustained, long term negative effect on self-reported physical and mental health. Furthermore, the data indicate that the 15D seems to be more responsive than the SF-6D when assessing utility and HRQOL in both types of fractures. This study will provide important information for guiding health policy and resource allocation in fracture patients, and for the proper interpretation of studies of health utility and HRQOL.
Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision-makers, and researchers worldwide).
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.
For more information: www.ispor.org